Marton Doleschall
senior scientist
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (1)
While most individuals with familial medullary thyroid carcinoma (fMTC) carry RET mutations, in some instances the causative mutations remain unknown. We studied two related families with RET-negative fMTC in 21 affected individuals through linkage analysis, exome/genome sequencing, and high-density array comparative genomic hybridization. We identified a novel heterozygous 40kb intragenic SLC30A9 deletion which segregated with the disease in all affected individuals. The mutant transcript escaped nonsense-mediated decay and resulted in the production of N-terminally truncated proteins via translation reinitiation from in-frame AUG codons located downstream of the deletion. These proteins showed increased stability and their expression in an MTC cell line increased cell proliferation and clonogenic capacity, supporting an oncogenic role. These findings expand the genetic background of fMTC beyond RET mutations and implicate translation reinitiation in the etiology of cancer susceptibility syndromes secondary to structural genomic variants.
Year:
2026
Collaborators (17)
Federica Begalli
Lecturer in Endocrinology
Queen Mary University of London
William Foulkes
Full Professor
McGill University
Horia Constantin Stanescu
University College London
Michael Witcher
Associate Professor
Lady Davis Institute for Medical Research
Maralyn Druce
-
Jolanta Krajewska
Associate Professor
Maria Sklodowska-Curie Institute - Oncology Center Gliwice Branch
Anne Barlier
Aix-Marseille University
Maria Alevizaki
Professor of Endocrinology
National and Kapodistrian University of Athens
Sabrina Chiloiro
Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia
Márta Korbonits
Deputy Director of the William Harvey Research Institute
Queen Mary University of London
Donato Iacovazzo
NIHR Clinical Lecturer
Queen Mary University of London
Malgorzata Oczko-Wojciechowska
Head of Department/Ph.D
Maria Sklodowska-Curie National Research Institute of Oncology
Jes Mathiesen
University of Southern Denmark
R Mihai
Oxford University Hospitals NHS Foundation Trust
Suvi Savola
Head of Oncogenetics
MRC-Holland
James R. Lupski
-
Miklós Tóth
professor
Semmelweis University
Make your next move.
Prepare your application
Review drafts before you send them.